Several years’ work has brought us finally to the island of Maui. Twelve nations have sent ministers and delegations here to attempt to conclude negotiations of the Trans-Pacific Partnership. The U.S. government, pressed by business lobbies and their election spending, will ask … Continue reading →
Access to medicines advocates from around the world recently gathered in Barcelona for a week-long seminar on the creatively persuasive arts. After a couple days’ lessons in history, neuroscience and organizing by the Center for Artistic Activism we took a … Continue reading →
Business interests lobby the US government to bully developing countries into changing their economic laws and practices so as to favor the commercial interests of multinationals. Unfortunately this can come at the expense of health, education and other sensitive public interests. We are countering the corporations’ analysis and arguing for a more independent US government policymaking that defends global health.
For example, I testified at a recent hearing by the US Trade Representative, criticizing the US Government’s Special 301 “Watch List.” At stake is India’s key role helping facilitate global access to affordable medicines. Read more here.